US4057685A
(en)
|
1972-02-02 |
1977-11-08 |
Abbott Laboratories |
Chemically modified endotoxin immunizing agent
|
DE2848965A1
(de)
|
1978-11-11 |
1980-05-22 |
Behringwerke Ag |
Verfahren zur herstellung von membranproteinen aus neisseria meningitidis und diese enthaltende vaccine
|
US4673574A
(en)
|
1981-08-31 |
1987-06-16 |
Anderson Porter W |
Immunogenic conjugates
|
US4459286A
(en)
|
1983-01-31 |
1984-07-10 |
Merck & Co., Inc. |
Coupled H. influenzae type B vaccine
|
US4663160A
(en)
|
1983-03-14 |
1987-05-05 |
Miles Laboratories, Inc. |
Vaccines for gram-negative bacteria
|
US4761283A
(en)
|
1983-07-05 |
1988-08-02 |
The University Of Rochester |
Immunogenic conjugates
|
US4808700A
(en)
|
1984-07-09 |
1989-02-28 |
Praxis Biologics, Inc. |
Immunogenic conjugates of non-toxic E. coli LT-B enterotoxin subunit and capsular polymers
|
IT1187753B
(it)
|
1985-07-05 |
1987-12-23 |
Sclavo Spa |
Coniugati glicoproteici ad attivita' immunogenica trivalente
|
US4803070A
(en)
*
|
1986-04-15 |
1989-02-07 |
Ribi Immunochem Research Inc. |
Immunological emulsion adjuvants for polysaccharide vaccines
|
US5204098A
(en)
|
1988-02-16 |
1993-04-20 |
The United States Of America As Represented By The Department Of Health And Human Services |
Polysaccharide-protein conjugates
|
US4912094B1
(en)
|
1988-06-29 |
1994-02-15 |
Ribi Immunochem Research Inc. |
Modified lipopolysaccharides and process of preparation
|
NL8802046A
(nl)
|
1988-08-18 |
1990-03-16 |
Gen Electric |
Polymeermengsel met polyester en alkaansulfonaat, daaruit gevormde voorwerpen.
|
DE3841091A1
(de)
|
1988-12-07 |
1990-06-13 |
Behringwerke Ag |
Synthetische antigene, verfahren zu ihrer herstellung und ihre verwendung
|
EP0378881B1
(de)
|
1989-01-17 |
1993-06-09 |
ENIRICERCHE S.p.A. |
Synthetische Peptide und deren Verwendung als allgemeine Träger für die Herstellung von immunogenischen Konjugaten, die für die Entwicklung von synthetischen Impfstoffen geeignet sind
|
JPH0832638B2
(ja)
|
1989-05-25 |
1996-03-29 |
カイロン コーポレイション |
サブミクロン油滴乳剤を含んで成るアジュバント製剤
|
CA2063271A1
(en)
|
1989-07-14 |
1991-01-15 |
Subramonia Pillai |
Cytokine and hormone carriers for conjugate vaccines
|
IT1237764B
(it)
|
1989-11-10 |
1993-06-17 |
Eniricerche Spa |
Peptidi sintetici utili come carriers universali per la preparazione di coniugati immunogenici e loro impiego per lo sviluppo di vaccini sintetici.
|
SE466259B
(sv)
|
1990-05-31 |
1992-01-20 |
Arne Forsgren |
Protein d - ett igd-bindande protein fraan haemophilus influenzae, samt anvaendning av detta foer analys, vacciner och uppreningsaendamaal
|
ATE128628T1
(de)
|
1990-08-13 |
1995-10-15 |
American Cyanamid Co |
Faser-hemagglutinin von bordetella pertussis als träger für konjugierten impfstoff.
|
IL101007A
(en)
|
1992-02-18 |
1997-08-14 |
Pharmos Ltd |
Dry stable compositions prepared by lyophilization
|
IT1262896B
(it)
|
1992-03-06 |
1996-07-22 |
|
Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini.
|
IL102687A
(en)
|
1992-07-30 |
1997-06-10 |
Yeda Res & Dev |
Conjugates of poorly immunogenic antigens and synthetic pepide carriers and vaccines comprising them
|
US5425946A
(en)
|
1992-08-31 |
1995-06-20 |
North American Vaccine, Inc. |
Vaccines against group C Neisseria meningitidis
|
DE69331495T2
(de)
|
1992-08-31 |
2002-10-31 |
Baxter Healthcare Sa |
Impfstoffe gegen neisseria meningitidis gruppe c
|
AU5543294A
(en)
|
1993-10-29 |
1995-05-22 |
Pharmos Corp. |
Submicron emulsions as vaccine adjuvants
|
GB9422096D0
(en)
*
|
1994-11-02 |
1994-12-21 |
Biocine Spa |
Combined meningitis vaccine
|
IL117483A
(en)
|
1995-03-17 |
2008-03-20 |
Bernard Brodeur |
MENINGITIDIS NEISSERIA shell protein is resistant to proteinase K.
|
US6180111B1
(en)
|
1995-05-18 |
2001-01-30 |
University Of Maryland |
Vaccine delivery system
|
US6080725A
(en)
|
1997-05-20 |
2000-06-27 |
Galenica Pharmaceuticals, Inc. |
Immunostimulating and vaccine compositions employing saponin analog adjuvants and uses thereof
|
AU7701098A
(en)
|
1997-05-28 |
1998-12-30 |
Michael A. Apicella |
Laft mutants of pathogenic gram-negative bacteria
|
GB9711964D0
(en)
|
1997-06-09 |
1997-08-06 |
Medical Res Council |
Live attenuated vaccines
|
GB9713156D0
(en)
|
1997-06-20 |
1997-08-27 |
Microbiological Res Authority |
Vaccines
|
WO1999010497A1
(en)
|
1997-08-21 |
1999-03-04 |
De Staat Der Nederlanden, Vertegenwoordigd Door De Minister Van Welzijn, Volksgezondheid En Cultuur |
Novel mutants of gram negative mucosal bacteria and application thereof in vaccines
|
BR9813930A
(pt)
|
1997-11-06 |
2006-12-19 |
Chiron Spa |
antìgeno neisserial
|
EP1047784B2
(de)
|
1998-01-14 |
2015-03-18 |
Novartis Vaccines and Diagnostics S.r.l. |
Antigene aus neisseria meningitidis
|
JP4768121B2
(ja)
*
|
1998-02-05 |
2011-09-07 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
Mageファミリーからの腫瘍関連抗原及びそれらをコードする核酸配列、融合タンパク質の及びワクチン接種のための組成物の調製のための使用
|
US7018637B2
(en)
|
1998-02-23 |
2006-03-28 |
Aventis Pasteur, Inc |
Multi-oligosaccharide glycoconjugate bacterial meningitis vaccines
|
US6645503B1
(en)
|
1998-03-10 |
2003-11-11 |
Wyeth Holdings Corporation |
Antigenic conjugates of conserved lipopolysaccharides of gram negative bacteria
|
NZ532665A
(en)
|
1998-05-01 |
2005-11-25 |
Inst Genomic Research |
Neisseria meningitidis antigens and compositions
|
EP1741443B1
(de)
*
|
1998-05-29 |
2014-05-21 |
Novartis Vaccines and Diagnostics, Inc. |
Kombinierte Meningitis B/C Impfstoffe
|
JP5074644B2
(ja)
*
|
1998-05-29 |
2012-11-14 |
ノバルティス バクシンズ アンド ダイアグノスティックス,インコーポレーテッド |
組合わせの髄膜炎菌b/cワクチン
|
CA2340692A1
(en)
|
1998-08-19 |
2000-03-02 |
North American Vaccine, Inc. |
Immunogenic .beta.-propionamido-linked polysaccharide protein conjugate useful as a vaccine produced using an n-acryloylated polysaccharide
|
MXPA01003557A
(es)
|
1998-10-09 |
2004-04-05 |
Chiron Corp |
Secuencias genomicas de neisseria y metodos para su uso.
|
GB9823978D0
(en)
|
1998-11-02 |
1998-12-30 |
Microbiological Res Authority |
Multicomponent meningococcal vaccine
|
WO2000026384A1
(en)
|
1998-11-03 |
2000-05-11 |
De Staat Der Nederlanden, Vertegenwoordigd Door De Minister Van Welzijn, Volksgezondheid En Cultuur |
Lps with reduced toxicity from genetically modified gram negative bacteria
|
AU1626199A
(en)
|
1998-12-04 |
2000-06-26 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
A vi-repa conjugate vaccine for immunization against salmonella typhi
|
BR0009163A
(pt)
|
1999-03-19 |
2001-12-26 |
Smithkline Beecham Biolog |
Vacina
|
JP2002541808A
(ja)
|
1999-04-09 |
2002-12-10 |
テクラブ, インコーポレイテッド |
ポリサッカリド結合体ワクチンのための組換えトキシンaタンパク質キャリア
|
GB9918319D0
(en)
|
1999-08-03 |
1999-10-06 |
Smithkline Beecham Biolog |
Vaccine composition
|
US6531131B1
(en)
|
1999-08-10 |
2003-03-11 |
The United States Of America As Represented By The Department Of Health And Human Services |
Conjugate vaccine for Neisseria meningitidis
|
GB9925559D0
(en)
|
1999-10-28 |
1999-12-29 |
Smithkline Beecham Biolog |
Novel method
|
WO2001034642A2
(en)
|
1999-11-12 |
2001-05-17 |
University Of Iowa Research Foundation |
Control of neisserial membrane synthesis
|
EP2275129A3
(de)
|
2000-01-17 |
2013-11-06 |
Novartis Vaccines and Diagnostics S.r.l. |
Ergänzter Außenmembranvesikel-Impfstoff gegen Meningokokken
|
WO2001064920A2
(en)
|
2000-02-28 |
2001-09-07 |
Chiron Spa |
Hybrid expression of neisserial proteins
|
GB0007432D0
(en)
|
2000-03-27 |
2000-05-17 |
Microbiological Res Authority |
Proteins for use as carriers in conjugate vaccines
|
NO20002828D0
(no)
|
2000-06-02 |
2000-06-02 |
Statens Inst For Folkehelse |
Proteinholdig vaksine mot Neisseria meningtidis serogruppe samt fremgangsmÕte ved fremstilling derav
|
JP5511117B2
(ja)
|
2000-07-27 |
2014-06-04 |
チルドレンズ ホスピタル アンド リサーチ センター アット オークランド |
髄膜炎菌に起因する疾患に対する広域防御のためのワクチン
|
GB0103170D0
(en)
|
2001-02-08 |
2001-03-28 |
Smithkline Beecham Biolog |
Vaccine composition
|
PT2332581E
(pt)
|
2001-01-23 |
2015-10-16 |
Sanofi Pasteur Inc |
Vacina meningocócica tri- ou tetravalente de conjugados de polissacárido e crm-197
|
GB0103171D0
(en)
|
2001-02-08 |
2001-03-28 |
Smithkline Beecham Biolog |
Vaccine composition
|
AU2002309706A1
(en)
|
2001-05-11 |
2002-11-25 |
Aventis Pasteur, Inc. |
Novel meningitis conjugate vaccine
|
GB0115176D0
(en)
|
2001-06-20 |
2001-08-15 |
Chiron Spa |
Capular polysaccharide solubilisation and combination vaccines
|
GB0121591D0
(en)
|
2001-09-06 |
2001-10-24 |
Chiron Spa |
Hybrid and tandem expression of neisserial proteins
|
DE60325565D1
(de)
|
2002-03-26 |
2009-02-12 |
Novartis Vaccines & Diagnostic |
Modifizierte saccharide mit verbesserter stabilität in wasser
|
GB0302218D0
(en)
*
|
2003-01-30 |
2003-03-05 |
Chiron Sri |
Vaccine formulation & Mucosal delivery
|
GB0213622D0
(en)
|
2002-06-13 |
2002-07-24 |
Glaxosmithkline Biolog Sa |
Vaccine Corporation
|
CA2493124C
(en)
|
2002-08-02 |
2014-04-29 |
Glaxosmithkline Biologicals S.A. |
Vaccine
|
GB0218821D0
(en)
*
|
2002-08-13 |
2002-09-18 |
Glaxosmithkline Biolog Sa |
Novel compositions
|
GB0220194D0
(en)
|
2002-08-30 |
2002-10-09 |
Chiron Spa |
Improved vesicles
|
CA2823937A1
(en)
*
|
2002-10-07 |
2004-04-22 |
Novartis Vaccines And Diagnostics, Inc. |
Hiv vaccine formulations
|
ATE492288T1
(de)
|
2002-10-11 |
2011-01-15 |
Novartis Vaccines & Diagnostic |
Polypeptidimpstoffe zum breiten schutz gegen hypervirulente meningokokken-linien
|
PT2279746E
(pt)
*
|
2002-11-15 |
2013-12-09 |
Novartis Vaccines & Diagnostic |
Proteínas de superfície de neisseria meningitidis
|
GB0227346D0
(en)
|
2002-11-22 |
2002-12-31 |
Chiron Spa |
741
|
JP4827726B2
(ja)
*
|
2003-01-30 |
2011-11-30 |
ノバルティス ヴァクシンズ アンド ダイアグノスティクス エスアールエル |
複数の髄膜炎菌血清群に対する注射可能ワクチン
|
AU2004226605A1
(en)
*
|
2003-04-02 |
2004-10-14 |
Coley Pharmaceutical Group, Ltd. |
Immunostimulatory nucleic acid oil-in-water formulations for topical application
|
GB0316560D0
(en)
|
2003-07-15 |
2003-08-20 |
Chiron Srl |
Vesicle filtration
|
CN103357002A
(zh)
*
|
2003-10-02 |
2013-10-23 |
诺华疫苗和诊断有限公司 |
多种脑膜炎球菌血清群的液体疫苗
|
GB0323103D0
(en)
|
2003-10-02 |
2003-11-05 |
Chiron Srl |
De-acetylated saccharides
|
US7628995B2
(en)
*
|
2003-12-23 |
2009-12-08 |
Glaxosmithkline Biologicals S.A. |
Outer membrane vesicles and uses thereof
|
DK1742659T3
(da)
|
2004-04-05 |
2013-06-03 |
Zoetis P Llc |
Mikrofluidiserede olie-i-vand-emulsioner og vaccinesammensætninger
|
GB0409745D0
(en)
*
|
2004-04-30 |
2004-06-09 |
Chiron Srl |
Compositions including unconjugated carrier proteins
|
GB0419627D0
(en)
|
2004-09-03 |
2004-10-06 |
Chiron Srl |
Immunogenic bacterial vesicles with outer membrane proteins
|
CA2588089C
(en)
*
|
2004-11-15 |
2015-06-23 |
Novartis Vaccines And Diagnostics Inc. |
Immunogenic compositions containing anthrax antigen, biodegradable polymer microparticles, and polynucleotide-containing immunological adjuvant
|
JP4993750B2
(ja)
|
2005-01-27 |
2012-08-08 |
チルドレンズ ホスピタル アンド リサーチ センター アット オークランド |
髄膜炎菌に起因する疾患に対する広域防御のための、gna1870を基にした小胞ワクチン
|
PE20061428A1
(es)
*
|
2005-03-23 |
2007-01-16 |
Glaxosmithkline Biolog Sa |
Formulacion de vacuna que comprende un adyuvante de emulsion aceite en agua y 3d-mpl
|
US20060228369A1
(en)
|
2005-04-11 |
2006-10-12 |
Program For Appropriate Technology In Health |
Stabilization and preservation of temperature-sensitive vaccines
|
US7691368B2
(en)
|
2005-04-15 |
2010-04-06 |
Merial Limited |
Vaccine formulations
|
US8156755B2
(en)
*
|
2005-06-03 |
2012-04-17 |
Intervet International B.V. |
Refrigerator for storing vials and cartridge for use in the same
|
US8431136B2
(en)
|
2005-06-27 |
2013-04-30 |
Glaxosmithkline Biologicals S.A. |
Immunogenic composition
|
US8703095B2
(en)
|
2005-07-07 |
2014-04-22 |
Sanofi Pasteur S.A. |
Immuno-adjuvant emulsion
|
JO2813B1
(en)
|
2005-12-22 |
2014-09-15 |
جلاكسو سميث كلاين بايولوجيكالز اس.ايه |
A vaccine with multiple pneumococcal saccharides
|
CA2643322C
(en)
*
|
2006-02-24 |
2015-07-21 |
Novartis Ag |
Microparticles containing biodegradable polymer and cationic polysaccharide for use in immunogenic compositions
|
GB0700135D0
(en)
*
|
2007-01-04 |
2007-02-14 |
Glaxosmithkline Biolog Sa |
Vaccine
|
EP2152302B1
(de)
*
|
2007-06-04 |
2015-10-07 |
GlaxoSmithKline Biologicals SA |
Formulierung eines impfstoffes gegen meningitis
|